#MedicinesforAll
Our Vision is that all Irish Patients can afford and access the medicines they need to get well, stay well and live well.
Our Goals
As an organisation our core objective is to improve the way Ireland procures and supplies medicines, in order to expand patient access to affordable, lifesaving and life-enhancing treatment.
- Enhance access to safe, high-quality medicines for patients across Ireland at an affordable price.
- Safeguard the supply of medicines to Ireland by ensuring supply chains remain secure and reliable.
- Innovate our approach to acquiring, supplying, and distributing medicines with the dual objective of pushing down costs and delivering greater equality of access nationwide.
- Inform key stakeholders of the specific and wider benefits associated with the increased usage of off-patent medicines.
About us
Medicines for Ireland is a pharmaceutical industry body committed to affecting real change and reforms that guarantee patients across Ireland have access the medicines they need at affordable prices.
Since its foundation in 2016, Medicines for Ireland has been promoting the benefits of the increased use of non-patient medicines (known also as generic, biosimilar, and value-added medicines) in Ireland.
Our members are the suppliers of the majority of medicine in Ireland to the HSE and patients directly.
Our Footprint
- Over the past year, MFI members supplied 78% of generic medicines in Ireland.
- Our members supplied over €53.5 million prescription medicines to Irish patients from March 2021 to March 2022.
- MFI played a pivotal role in a new Framework Agreement on the supply and pricing of non-originator, generic, biosimilar, and hybrid medicines, announced by Government last year. It is estimated to reduce the State spend on medicines by up to €700 million.
What we do?
Since its foundation in 2016, Medicines for Ireland has been promoting the benefits of the increased use of non-patient medicines (known also as generic, biosimilar, and value-added medicines) in Ireland. As an organisation, our core objective is to improve the way Ireland procures and supplies medicines, in order to expand patient access to affordable, lifesaving and life-enhancing treatment.Our Work
- Produce up-to-date research, data, and analysis on the benefits of off patient medicines
- Deliver industry insight and expertise to help improve the way we procure and supply to help more patients access treatment at a lower cost
- Inform and education through reports, infographic and learning events
- Drive reform and meaningful change through engagement with key stakeholder including NGO, patient groups, Government and State bodies
